Blood tests may show increased bilirubin, alkaline phosphatase, GGT, ALT, AST, or white blood cells when biliary obstruction or inflammation is present
The FDA emphasizes the importance of consulting with healthcare providers before embarking on any new treatment regimen to mitigate potential risks
Similar precautions apply across GLP-1based treatments due to shared mechanisms
If you have questions about which lab tests to have during your treatment with Mounjaro, talk with the healthcare professional ordering the tests
No, compounded formulations are not FDA-approved products
Your GLP-1 or peptide therapy is adjusted based on your bodys unique rate of fat loss, appetite suppression response, and energetic well-being